410 related articles for article (PubMed ID: 24115839)
1. 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.
Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Drug Des Devel Ther; 2013; 7():1157-78. PubMed ID: 24115839
[TBL] [Abstract][Full Text] [Related]
2. A chelating agent possessing cytotoxicity and antimicrobial activity: 7-morpholinomethyl-8-hydroxyquinoline.
Shen AY; Chen CP; Roffler S
Life Sci; 1999; 64(9):813-25. PubMed ID: 10075114
[TBL] [Abstract][Full Text] [Related]
3. Metal ions, Alzheimer's disease and chelation therapy.
Budimir A
Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339
[TBL] [Abstract][Full Text] [Related]
4. 8-Hydroxyquinolines in medicinal chemistry: A structural perspective.
Oliveri V; Vecchio G
Eur J Med Chem; 2016 Sep; 120():252-74. PubMed ID: 27191619
[TBL] [Abstract][Full Text] [Related]
5. A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation.
Cacciatore I; Cornacchia C; Fornasari E; Baldassarre L; Pinnen F; Sozio P; Di Stefano A; Marinelli L; Dean A; Fulle S; Di Filippo ES; La Rovere RM; Patruno A; Ferrone A; Di Marco V
ChemMedChem; 2013 Nov; 8(11):1818-29. PubMed ID: 24106097
[TBL] [Abstract][Full Text] [Related]
6. New cyclodextrin-bearing 8-hydroxyquinoline ligands as multifunctional molecules.
Oliveri V; Puglisi A; Viale M; Aiello C; Sgarlata C; Vecchio G; Clarke J; Milton J; Spencer J
Chemistry; 2013 Oct; 19(41):13946-55. PubMed ID: 24038335
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring.
Scheibel LW; Adler A
Mol Pharmacol; 1982 Jul; 22(1):140-4. PubMed ID: 6811856
[No Abstract] [Full Text] [Related]
8. Nitric oxide-donating and reactive oxygen species-responsive prochelators based on 8-hydroxyquinoline as anticancer agents.
Zhang Y; Yang J; Meng T; Qin Y; Li T; Fu J; Yin J
Eur J Med Chem; 2021 Feb; 212():113153. PubMed ID: 33453603
[TBL] [Abstract][Full Text] [Related]
9. 8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis.
Shah S; Dalecki AG; Malalasekera AP; Crawford CL; Michalek SM; Kutsch O; Sun J; Bossmann SH; Wolschendorf F
Antimicrob Agents Chemother; 2016 Oct; 60(10):5765-76. PubMed ID: 27431227
[TBL] [Abstract][Full Text] [Related]
10. Drug design strategies with metal-hydroxyquinoline complexes.
Savić-Gajić IM; Savić IM
Expert Opin Drug Discov; 2020 Mar; 15(3):383-390. PubMed ID: 31829757
[No Abstract] [Full Text] [Related]
11. Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer's disease.
Yang X; Cai P; Liu Q; Wu J; Yin Y; Wang X; Kong L
Bioorg Med Chem; 2018 Jul; 26(12):3191-3201. PubMed ID: 29729985
[TBL] [Abstract][Full Text] [Related]
12. Insights of 8-hydroxyquinolines: A novel target in medicinal chemistry.
Gupta R; Luxami V; Paul K
Bioorg Chem; 2021 Mar; 108():104633. PubMed ID: 33513476
[TBL] [Abstract][Full Text] [Related]
13. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
Fernández-Bachiller MI; Pérez C; González-Muñoz GC; Conde S; López MG; Villarroya M; García AG; Rodríguez-Franco MI
J Med Chem; 2010 Jul; 53(13):4927-37. PubMed ID: 20545360
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional 8-hydroxyquinoline-appended cyclodextrins as new inhibitors of metal-induced protein aggregation.
Oliveri V; Attanasio F; Puglisi A; Spencer J; Sgarlata C; Vecchio G
Chemistry; 2014 Jul; 20(29):8954-64. PubMed ID: 24863958
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant Properties and the Formation of Iron Coordination Complexes of 8-Hydroxyquinoline.
Chobot V; Hadacek F; Bachmann G; Weckwerth W; Kubicova L
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544490
[TBL] [Abstract][Full Text] [Related]
16. Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease.
Knez D; Sosič I; Pišlar A; Mitrović A; Jukič M; Kos J; Gobec S
Curr Alzheimer Res; 2019; 16(9):801-814. PubMed ID: 31660830
[TBL] [Abstract][Full Text] [Related]
17. New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.
Fu CL; Hsu LS; Liao YF; Hu MK
Arch Pharm (Weinheim); 2016 May; 349(5):327-41. PubMed ID: 27027880
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial activity of selected aromatic chelators.
Scheibel LW; Adler A
Mol Pharmacol; 1980 Sep; 18(2):320-5. PubMed ID: 6775184
[No Abstract] [Full Text] [Related]
19. Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
Zheng H; Youdim MB; Fridkin M
J Med Chem; 2009 Jul; 52(14):4095-8. PubMed ID: 19485411
[TBL] [Abstract][Full Text] [Related]
20. PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study.
Summers KL; Dolgova NV; Gagnon KB; Sopasis GJ; James AK; Lai B; Sylvain NJ; Harris HH; Nichol HK; George GN; Pickering IJ
Metallomics; 2020 Dec; 12(12):1979-1994. PubMed ID: 33169753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
